These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 16043398)
21. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
23. Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. Cenacchi G; Papa V; Fanin M; Pegoraro E; Angelini C J Neurol; 2011 May; 258(5):746-52. PubMed ID: 21088848 [TBL] [Abstract][Full Text] [Related]
30. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. Koneczny I; Cossins J; Vincent A J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718 [TBL] [Abstract][Full Text] [Related]
31. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China. Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008 [TBL] [Abstract][Full Text] [Related]
32. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)]. Sanadze AG; Sidnev DV; Karganov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492 [TBL] [Abstract][Full Text] [Related]
33. Are MuSK antibodies the primary cause of myasthenic symptoms? Selcen D; Fukuda T; Shen XM; Engel AG Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594 [TBL] [Abstract][Full Text] [Related]
34. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034 [TBL] [Abstract][Full Text] [Related]
36. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis. Kwon YN; Woodhall M; Sung JJ; Kim KK; Lim YM; Kim H; Kim JE; Baek SH; Kim BJ; Park JS; Seok HY; Kim DS; Kwon O; Park KH; Sohn E; Bae JS; Yoon BN; Kim NH; Ahn SW; Choi K; Oh J; Park HJ; Shin KJ; Lee S; Park J; Kim SH; Seok JI; Bae DW; An JY; Joo IS; Choi SJ; Nam TS; Kim S; Park KJ; Kwon KH; Waters P; Hong YH J Neurol; 2023 Mar; 270(3):1478-1486. PubMed ID: 36396811 [TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis patients with anti-MuSK antibodies. Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061 [TBL] [Abstract][Full Text] [Related]
38. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases]. Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804 [TBL] [Abstract][Full Text] [Related]